Inactive Instrument
Innate Immunotherapeutics Ltd Stock Australian S.E.
Stocks
AU000000IIL6
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 66.73M 46.84M 40.72M 37.9M 34.8M 65.71M 4.47B 447M 175M 2.23B 176M 172M 7.46B | P/E 2027 * |
-5.65x | P/E 2028 * | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 51.23M 35.96M 31.26M 29.1M 26.71M 50.45M 3.43B 343M 135M 1.71B 135M 132M 5.73B | EV / Sales 2027 * |
-
| EV / Sales 2028 * | 4.52x |
| Free-Float |
90.48% | Yield 2027 * |
-
| Yield 2028 * | - |
| 1 day | -2.33% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-04 | |
Hamish George
DFI | Director of Finance/CFO | - | 2021-09-30 |
Jason Lickliter
CTO | Chief Tech/Sci/R&D Officer | - | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Peach
BRD | Director/Board Member | 70 | 2015-09-01 |
Warwick Tong
CHM | Chairman | - | 2018-05-24 |
Jane Bell
CHM | Chairman | - | 2026-06-29 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -10.64% | - | - | 46.84M | |
| +2.35% | +2.74% | +38.10% | +74.02% | 56.54B | |
| -1.18% | -6.74% | +25.36% | +61.89% | 53.6B | |
| -2.44% | +1.40% | -15.61% | -13.72% | 22.91B | |
| -2.85% | -7.78% | -9.28% | +352.92% | 21.37B | |
| +0.15% | +0.36% | +24.28% | -14.44% | 20.27B | |
| +0.50% | -1.94% | +32.32% | -28.89% | 17.56B | |
| -1.45% | -7.15% | +17.96% | +554.50% | 14.75B | |
| +3.41% | -6.61% | +162.81% | +287.77% | 13.53B | |
| -5.25% | -4.23% | +42.32% | +160.72% | 13.33B | |
| Average | -0.90% | -3.79% | +35.36% | +159.42% | 25.98B | |
| Weighted average by Cap. | -0.33% | -2.96% | +30.14% | +120.35% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | - | 10M 7.02M 6.1M 5.68M 5.21M 9.85M 670M 66.95M 26.28M 334M 26.36M 25.78M 1.12B |
| Net income | -11.6M -8.14M -7.08M -6.59M -6.05M -11.42M -777M -77.66M -30.48M -387M -30.58M -29.91M -1.3B | -3.6M -2.53M -2.2M -2.04M -1.88M -3.55M -241M -24.1M -9.46M -120M -9.49M -9.28M -403M |
| Net Debt | -15.5M -10.88M -9.46M -8.8M -8.08M -15.26M -1.04B -104M -40.73M -517M -40.86M -39.96M -1.73B | -21.5M -15.09M -13.12M -12.21M -11.21M -21.17M -1.44B -144M -56.49M -717M -56.68M -55.43M -2.41B |
Employees
-
